Market News for Pfizer Inc (PFE)
Pfizer Inc. NYSE: PFE helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its fourth-quarter earnings report....
MarketBeat - 2/5/2026 6:22:14 PM
More News for PFE
Stock Analysis for PFE
Related Stocks:
Pfizer hopes to differentiate itself in the obesity drug market with a once-monthly injection. The company plans to advance 20+ obesity therapy clinical studies in 2026....
The Motley Fool - 2/5/2026 4:45:00 AM
More News for PFE
Stock Analysis for PFE
Related Stocks:
Pfizer's monthly GLP-1 data prompts caution as new rival approaches Phase III Citi has reiterated its 'neutral' stance on Novo Nordisk (NYSE:NVO), warning that competition in the obesity drug market continues to intensify following promising phase II results from Pfizer's candidate MET-097i. At its full-year 2025 results, Pfizer released topline data from the VESPER-3 trial showing its monthly GLP-1 treatment for obesity, Metsera, achieved weight loss comparable to Eli Lilly's Zepbound and Novo's own CagriSema....
Proactive Investors - 2/4/2026 9:45:38 AM
More News for PFE
Stock Analysis for PFE
Related Stocks:
